Viewing Study NCT01256151


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-26 @ 4:31 PM
Study NCT ID: NCT01256151
Status: COMPLETED
Last Update Posted: 2021-01-28
First Post: 2010-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module